SK Group attempts to enter European Biopharmaceutical Market
SK Group is increasing its determination to take advantage of the European biopharmaceutical market. SK Biopharmaceuticals has been given the
Read more
Author: Kristina Bazan
Hugel applies for biologics license application (BLA) for its botulinum toxin (BTX) in US
Hugel said that it has applied for biologics license application (BLA) for its botulinum toxin (BTX) item, Letybo (50 and
Read more
Chime Biologics secures an absolute commitment of $190 investment
Chime Biologics, a China-based CDMO, secures an absolute commitment of $190 million investment from institutional financial investors. This round of
Read more
Study reveals new 3D bioprinting technique is beneficial for diabetes patients bone repairs
The bone defect is a significant issue for individuals with diabetes after fractures; however another strategy including 3D bioprinting of
Read more
Gland Pharma enters into an alliance with the Russian Direct Investment Fund (RDIF) to supply up to 252 million dosages of Russia’s Sputnik V Covid vaccine.
Drugmaker Gland Pharma on March 17 declared it had entered into an alliance with the Russian Direct Investment Fund (RDIF)
Read more
US Drugmaker Moderna announces the commencement of Covid 19 immunization trials for kids
US drugmaker Moderna on Tuesday said it has begun Covid-19 immunization trials for kids from a half year to less
Read more
Health Specialists baffled by suspensions of Covid immunizations created by AstraZeneca and Oxford
LONDON — Health specialists say they are baffled and confused by the whirlwind of suspensions of the Covid immunization created
Read more
US Food and Drug Administration (FDA) has affirmed Abbott’s Alinity
The US Food and Drug Administration (FDA) has affirmed Abbott’s Alinity m Resp-4-Plex molecular assay for crisis use. The test
Read more
Conflicts between England’s National Institute for Health and Care Excellence (NICE) and pharma organizations
Cost watchdogs at England’s National Institute for Health and Care Excellence (NICE) have conflicted consistently with pharma organizations over the
Read more
ProPharma Group declares acquisition of Diamond Pharma Services
ProPharma Group, a portfolio organization of Odyssey Investment Partners, declares the acquisition of Diamond Pharma Services. Diamond Pharma Services gives
Read more